ID   KC1AL_HUMAN             Reviewed;         337 AA.
AC   Q8N752; Q5T2N2;
DT   10-MAY-2004, integrated into UniProtKB/Swiss-Prot.
DT   22-JUL-2008, sequence version 2.
DT   12-APR-2017, entry version 126.
DE   RecName: Full=Casein kinase I isoform alpha-like;
DE            Short=CKI-alpha-like;
DE            EC=2.7.11.1;
DE   AltName: Full=CK1;
GN   Name=CSNK1A1L;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057823; DOI=10.1038/nature02379;
RA   Dunham A., Matthews L.H., Burton J., Ashurst J.L., Howe K.L.,
RA   Ashcroft K.J., Beare D.M., Burford D.C., Hunt S.E.,
RA   Griffiths-Jones S., Jones M.C., Keenan S.J., Oliver K., Scott C.E.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Andrews D.T.,
RA   Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J., Bannerjee R.,
RA   Barlow K.F., Bates K., Beasley H., Bird C.P., Bray-Allen S.,
RA   Brown A.J., Brown J.Y., Burrill W., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M.E., Clark S.Y., Clarke G., Clee C.M.,
RA   Clegg S.C., Cobley V., Collins J.E., Corby N., Coville G.J.,
RA   Deloukas P., Dhami P., Dunham I., Dunn M., Earthrowl M.E.,
RA   Ellington A.G., Faulkner L., Frankish A.G., Frankland J., French L.,
RA   Garner P., Garnett J., Gilbert J.G.R., Gilson C.J., Ghori J.,
RA   Grafham D.V., Gribble S.M., Griffiths C., Hall R.E., Hammond S.,
RA   Harley J.L., Hart E.A., Heath P.D., Howden P.J., Huckle E.J.,
RA   Hunt P.J., Hunt A.R., Johnson C., Johnson D., Kay M., Kimberley A.M.,
RA   King A., Laird G.K., Langford C.J., Lawlor S., Leongamornlert D.A.,
RA   Lloyd D.M., Lloyd C., Loveland J.E., Lovell J., Martin S.,
RA   Mashreghi-Mohammadi M., McLaren S.J., McMurray A., Milne S.,
RA   Moore M.J.F., Nickerson T., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K.M., Rice C.M., Searle S.,
RA   Sehra H.K., Shownkeen R., Skuce C.D., Smith M., Steward C.A.,
RA   Sycamore N., Tester J., Thomas D.W., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., Whitehead S.L., Willey D.L.,
RA   Wilming L., Wray P.W., Wright M.W., Young L., Coulson A., Durbin R.M.,
RA   Hubbard T., Sulston J.E., Beck S., Bentley D.R., Rogers J., Ross M.T.;
RT   "The DNA sequence and analysis of human chromosome 13.";
RL   Nature 428:522-528(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT GLU-42.
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   VARIANT [LARGE SCALE ANALYSIS] GLN-21.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
RN   [5]
RP   VARIANTS [LARGE SCALE ANALYSIS] GLY-5; TRP-21; SER-170; LYS-177;
RP   LEU-220; ASN-230 AND THR-257.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Casein kinases are operationally defined by their
CC       preferential utilization of acidic proteins such as caseins as
CC       substrates. It can phosphorylate a large number of proteins.
CC       Participates in Wnt signaling (By similarity). {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CK1 Ser/Thr
CC       protein kinase family. Casein kinase I subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL391383; CAI15195.1; -; Genomic_DNA.
DR   EMBL; CH471075; EAX08587.1; -; Genomic_DNA.
DR   EMBL; BC028723; AAH28723.1; -; mRNA.
DR   CCDS; CCDS9363.1; -.
DR   RefSeq; NP_660204.2; NM_145203.5.
DR   UniGene; Hs.512897; -.
DR   ProteinModelPortal; Q8N752; -.
DR   SMR; Q8N752; -.
DR   BioGrid; 125755; 13.
DR   IntAct; Q8N752; 6.
DR   STRING; 9606.ENSP00000369126; -.
DR   BindingDB; Q8N752; -.
DR   ChEMBL; CHEMBL5520; -.
DR   GuidetoPHARMACOLOGY; 1996; -.
DR   iPTMnet; Q8N752; -.
DR   PhosphoSitePlus; Q8N752; -.
DR   BioMuta; CSNK1A1L; -.
DR   DMDM; 212286065; -.
DR   EPD; Q8N752; -.
DR   MaxQB; Q8N752; -.
DR   PaxDb; Q8N752; -.
DR   PeptideAtlas; Q8N752; -.
DR   PRIDE; Q8N752; -.
DR   DNASU; 122011; -.
DR   Ensembl; ENST00000379800; ENSP00000369126; ENSG00000180138.
DR   GeneID; 122011; -.
DR   KEGG; hsa:122011; -.
DR   UCSC; uc001uwm.2; human.
DR   CTD; 122011; -.
DR   GeneCards; CSNK1A1L; -.
DR   H-InvDB; HIX0011244; -.
DR   HGNC; HGNC:20289; CSNK1A1L.
DR   HPA; HPA051334; -.
DR   neXtProt; NX_Q8N752; -.
DR   OpenTargets; ENSG00000180138; -.
DR   PharmGKB; PA134917108; -.
DR   eggNOG; KOG1164; Eukaryota.
DR   eggNOG; ENOG410XPGP; LUCA.
DR   GeneTree; ENSGT00760000119040; -.
DR   HOGENOM; HOG000182055; -.
DR   HOVERGEN; HBG000176; -.
DR   InParanoid; Q8N752; -.
DR   KO; K08957; -.
DR   OMA; PYREDKH; -.
DR   OrthoDB; EOG091G0AFG; -.
DR   PhylomeDB; Q8N752; -.
DR   TreeFam; TF354246; -.
DR   SignaLink; Q8N752; -.
DR   SIGNOR; Q8N752; -.
DR   GenomeRNAi; 122011; -.
DR   PRO; PR:Q8N752; -.
DR   Proteomes; UP000005640; Chromosome 13.
DR   Bgee; ENSG00000180138; -.
DR   CleanEx; HS_CSNK1A1L; -.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0030529; C:intracellular ribonucleoprotein complex; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IBA:GO_Central.
DR   GO; GO:0000902; P:cell morphogenesis; IEA:Ensembl.
DR   GO; GO:0018105; P:peptidyl-serine phosphorylation; IBA:GO_Central.
DR   GO; GO:0006909; P:phagocytosis; IBA:GO_Central.
DR   GO; GO:0008360; P:regulation of cell shape; IBA:GO_Central.
DR   GO; GO:0016055; P:Wnt signaling pathway; IBA:GO_Central.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   2: Evidence at transcript level;
KW   Acetylation; ATP-binding; Complete proteome; Cytoplasm; Kinase;
KW   Nucleotide-binding; Polymorphism; Reference proteome;
KW   Serine/threonine-protein kinase; Transferase; Wnt signaling pathway.
FT   INIT_MET      1      1       Removed. {ECO:0000250|UniProtKB:P48729}.
FT   CHAIN         2    337       Casein kinase I isoform alpha-like.
FT                                /FTId=PRO_0000192830.
FT   DOMAIN       17    285       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND      23     31       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   ACT_SITE    136    136       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10027}.
FT   BINDING      46     46       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOD_RES       8      8       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P48729}.
FT   VARIANT       5      5       S -> G (in dbSNP:rs56224973).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042074.
FT   VARIANT      21     21       R -> Q (in a colorectal cancer sample;
FT                                somatic mutation; dbSNP:rs56158728).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_036450.
FT   VARIANT      21     21       R -> W (in dbSNP:rs56158728).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042075.
FT   VARIANT      42     42       D -> E (in dbSNP:rs9576175).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_042076.
FT   VARIANT     170    170       R -> S (in dbSNP:rs17773251).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_034047.
FT   VARIANT     177    177       E -> K (in dbSNP:rs17054882).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042077.
FT   VARIANT     220    220       P -> L (in dbSNP:rs56252856).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042078.
FT   VARIANT     230    230       K -> N (in dbSNP:rs56252523).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042079.
FT   VARIANT     257    257       A -> T (in dbSNP:rs55895045).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042080.
FT   CONFLICT    225    225       R -> K (in Ref. 3; AAH28723).
FT                                {ECO:0000305}.
SQ   SEQUENCE   337 AA;  39086 MW;  6110F854D739B142 CRC64;
     MTNNSGSKAE LVVGGKYKLV RKIGSGSFGD VYLGITTTNG EDVAVKLESQ KVKHPQLLYE
     SKLYTILQGG VGIPHMHWYG QEKDNNVLVM DLLGPSLEDL FNFCSRRFTM KTVLMLADQM
     ISRIEYVHTK NFLHRDIKPD NFLMGTGRHC NKLFLIDFGL AKKYRDNRTR QHIPYREDKH
     LIGTVRYASI NAHLGIEQSR RDDMESLGYV FMYFNRTSLP WQGLRAMTKK QKYEKISEKK
     MSTPVEVLCK GFPAEFAMYL NYCRGLRFEE VPDYMYLRQL FRILFRTLNH QYDYTFDWTM
     LKQKAAQQAA SSSGQGQQAQ TQTGKQTEKN KNNVKDN
//
